BRIEF-Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.

BRIEF-Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.

Harmony Biosciences Holdings Inc : * HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.

* ZYNERBA PHARMACEUTICALS INC - PROPOSED DEAL FOR PURCHASE PRICE OF $1.1059 PER SHARE IN CASH, OR $60 MILLION IN AGGREGATE * ZYNERBA - DEAL MAY INCLUDE NON-TRADEABLE CONTINGENT VALUE RIGHT PER SHARE, REPRESENTING RIGHT TO GET POTENTIAL ADDITIONAL PAYMENTS OF UP TO $140 MILLION

* ZYNERBA PHARMACEUTICALS INC - HARMONY WILL FUND TRANSACTION FROM ITS EXISTING CASH ON HAND Source text for Eikon: Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.